Nov 4, 2024 | Business News, Investor News
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics Posted on April 27, 2022 The £1 million grant will support the development of the first Oral Food Challenges (OFCs) for paediatric patients to diagnose...
Nov 4, 2024 | Business News, Investor News
UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans Posted on April 21, 2020 Reacta Biotech raises £1.25m to secure MHRA site license Once achieved, the license will enable significantly expanded production of its Oral Food...
